- Imabiotech Company News Section

Imabiotech Information
  • Fontaine Edma
  • URL:
  • ImaBiotech is a contract research organization (CRO) that offers services in mass spectrometry imaging (MSI); along with developing and implementing new imaging technologies, such as Quantinetix%u2122 and Multimaging%u2122. The main facility is located in Europe (Lille, France), with an office in North America (Cambridge, MA) and a distributor in Asia (Tokyo, Japan). In order to accelerate drug development, ImaBiotech offers Mass Spectrometry Services, such as MALDI high resolution mass spectrometry imaging to provide a cost effective solution to preclinical and clinical studies. This molecular technique is used both qualitatively and quantitatively.
Imabiotech Press Release -

  • ImaBiotech signs license agreement with Lawrence Berkeley National Laboratory
  • ImaBiotech, a CRO company developing and offering mass spectrometry imaging (MSI) services, applications, and software, announces today a license agreement with Lawrence Berkeley National Laboratory (Berkeley Lab) to "OpenMSI" intellectual property to support ImaBiotech Multimaging™ technology.
  • ImaBiotech's Multimaging™ technology accelerates drug pharmacokinetic, pharmacology, toxicology, and formulation evaluation. Multimaging™ allows for ...
  • April 15, 2016